Hematopoietic Stem Cell TransplantationBone Marrow TransplantationTransplantation, HomologousHematopoietic Stem CellsGraft vs Host DiseaseTransplantation, AutologousStem Cell TransplantationBone MarrowTransplantation ConditioningBone Marrow CellsLeukemiaHematologic NeoplasmsWhole-Body IrradiationTransplantation ChimeraPeripheral Blood Stem Cell TransplantationStem CellsTissue DonorsGraft SurvivalLeukemia, Myeloid, AcuteBusulfanHistocompatibility TestingLiver TransplantationTreatment OutcomeHistocompatibilityHematopoiesisAnemia, AplasticRecurrenceCord Blood Stem Cell TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRemission InductionCombined Modality TherapyRetrospective StudiesGraft vs Leukemia EffectImmunosuppressive AgentsCyclophosphamideAntigens, CD34Hematopoietic Stem Cell MobilizationPrecursor Cell Lymphoblastic Leukemia-LymphomaTransplantation, IsogeneicKidney TransplantationHepatic Veno-Occlusive DiseaseMyeloablative AgonistsTime FactorsMice, Inbred C57BLBone and BonesCell DifferentiationChimerismHematologic DiseasesHLA AntigensTransplantation ImmunologyMyelodysplastic SyndromesSurvival AnalysisSevere Combined ImmunodeficiencyBone Marrow PurgingMultiple MyelomaSurvival RateAcute DiseaseColony-Forming Units AssayGraft vs Tumor EffectGraft RejectionLymphocyte TransfusionDisease-Free SurvivalFlow CytometryCell TransplantationLymphocyte DepletionMesenchymal Stem Cell TransplantationMelphalanT-LymphocytesCell LineageLymphoma, Non-HodgkinImmunosuppressionAntineoplastic Combined Chemotherapy ProtocolsBone Marrow DiseasesGranulocyte Colony-Stimulating FactorLeukemia, MyeloidHeart TransplantationCytomegalovirus InfectionsVidarabineSiblingsRadiation ChimeraFollow-Up StudiesCytarabineUnrelated DonorsCells, CulturedAntilymphocyte SerumLung TransplantationSalvage TherapyOrgan TransplantationFetal BloodCell SeparationPrognosisStem Cell NicheCyclosporineOpportunistic InfectionsEmbryonic Stem CellsAdult Stem CellsLeukocyte TransfusionFatal OutcomeLymphomaTransplantation